Clinical trial
Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to…
NCT00476073 · Mundipharma Research Limited, Industry · Completed
Key facts
| NCT number | NCT00476073 |
|---|---|
| Title | Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma |
| Lead sponsor | Mundipharma Research Limited, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma Bronchiale |
| Intervention type | Drug |
| Interventions | FLUTIFORM® (Formoterol fumarate / Fluticasone propionate) |
| Enrollment | 228 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | Oct 24, 2018 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: